Tallac announces first patient treated with TAC-001
29th July 2022 Uncategorised 0The phase 1/2 study is for patients with advanced or metastatic solid tumours
More: Tallac announces first patient treated with TAC-001
Source: News
The phase 1/2 study is for patients with advanced or metastatic solid tumours
More: Tallac announces first patient treated with TAC-001
Source: News
© 1994 - 2026 B.M. Pharmaceuticals